Komodo Health
Komodo Health is a healthcare technology company providing patient-level insights through its proprietary Healthcare Map™ and Marmot AI platforms.
Secondary Market Price
How Komodo Health Measures Up
To help you manage your Komodo Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Komodo Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Komodo Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Komodo Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Komodo Health is a healthcare technology company that provides data-driven insights to clients in the life sciences, government, and financial services sectors. The company’s main product is its Healthcare Map platform, which provides a de-identified view of longitudinal patient data. This platform is used by life sciences companies, patient advocacy groups, healthcare practitioners, and payers to analyze patient journeys, extend the reach of therapies, and address unmet medical needs across more than fifty therapeutic areas. Founded in 2014 by Arif Nathoo and Web Sun, the company is headquartered in New York and has grown to employ between 501 and 1,000 people.
The company is currently focused on developing its AI-powered analytics platform, Marmot, which is designed to provide real-time healthcare insights. Recent announcements underscore this focus on AI and data application. Komodo Health entered a strategic partnership with GeneDx to build a comprehensive dataset for rare diseases, aiming to identify patients earlier and address gaps in care. The company also used its Marmot platform to analyze the treatment continuity for over 4,400 patients following the withdrawal of a sickle cell therapy. Company executives have also been active at industry events, with CEO Arif Nathoo presenting on the role of AI and the Marmot platform in healthcare analytics.
- Andreessen Horowitz
- Oak HC/FT
- IA Ventures
- Felicis Ventures
- Tiger Global Management
- Casdin Capital
- ICONIQ Growth
- SVB Capital
- Co-Founder, Arif Nathoo
- Co-Founder, Web Sun
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Komodo Health worth joining?
Deciding to join any company is a personal choice that depends on your career goals, the company culture, and other factors beyond compensation. If you receive an equity offer, a platform like Prospect can help you understand its potential value to make a more informed decision.
What should I do with my Komodo Health stock?
The right strategy for your private company stock depends on your personal financial goals, risk tolerance, and tax situation. Tools like Prospect can provide customized, tax-optimized strategies for exercising options and planning for liquidity events.
Can you sell Komodo Health stock?
As Komodo Health is a private company, selling stock is typically possible through company-approved tender offers or on secondary markets, though restrictions often apply. Platforms such as Prospect offer tools to help you navigate tender offers and identify which shares are most tax-optimal to sell.
How can I find the value of my Komodo Health stock?
The value of private stock is often based on its latest 409A valuation, the price from a recent funding round, or transactions on secondary markets. To help forecast potential future value, Prospect uses predictive models and provides data on current secondary market prices.
What is Komodo Health's equity worth?
The worth of your specific equity grant is determined by the company's most recent 409A valuation and the number of shares you hold. You can use a platform like Prospect to upload your equity details and project the potential future value of your holdings.
What is Komodo Health's stock ticker symbol?
Since Komodo Health is a private company, it is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they go public through an Initial Public Offering (IPO).
Can I buy or sell Komodo Health stock?
Employees can typically "buy" stock by exercising their vested options, while selling usually occurs during tender offers or on secondary markets, subject to company approval. Prospect provides tools to help you create tax-efficient strategies for both exercising options and selling your shares.
What is the criteria to buy or invest in Komodo Health stock?
Investing in a private company like Komodo Health is generally restricted to employees receiving equity compensation or accredited investors participating in formal funding rounds. If you are an employee with equity, platforms like Prospect can help you manage your holdings and make strategic decisions.
